Axogen (AXGN) Stock: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$36.48
0.31 (0.86%)
▲
5d:
+3.81%
30d:
-18.1%
90d:
-8.18%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 28, 2026
5d
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AXGN trading at deep discount. Market pricing in -4.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: AXGN trading at deep discount. Market pricing in -4.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.10
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.80
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $36.48, which is considered slightly low relative to its 30-day fair value range of $35.94 to $43.89. From a valuation perspective, the stock is trading at a discount (Forward PE: 50.6) compared to its historical average (58.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $37.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN scores 98/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $53.55 (+46.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $37.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN scores 98/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $53.55 (+46.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$35.94 -
$43.89
Company Quality Score
75/100
(STRONG BUY)
Options IV Signal
2th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
92.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 2th percentile)
- BULLISH: Strong technical setup (98/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.8% below Wall St target ($53.55)
- BULLISH: Bottoming setup score 98/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$35.94 -
$43.89
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$4.68
(12.8%)
Support & Resistance Levels
Support Level
$34.11
Resistance Level
$37.47
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.60
Wall Street Target
$53.55
(+46.8%)
Revenue Growth (YoY)
23.1%
Profit Margin
-13.4%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
50.6 vs 58.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$34.84
(-5%)
2-Year Target
$33.27
(-9%)
3-Year Target
$31.77
(-13%)
3-Yr Target (if PE normalizes)
(PE: 51→58)
$36.49
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 50.6, Growth: 50.7%)
$123.12
(+238%)
Base:
(SPY PE: 19.9, Growth: 50.7%)
$48.33
(+33%)
Bear:
(PE: 16.9, Growth: 50.7%)
$41.08
(+13%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 50.6 to 58.1
Stabilization Target:
$41.89
(+14.8%)
PE Expansion Potential:
+14.8%
Share & Embed Analysis
Last updated: October 22, 2026 4:03 AM ET
Data refreshes hourly during market hours. Next update: 5:03 AM
Data refreshes hourly during market hours. Next update: 5:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
